Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP/PS1 double transgenic model of Alzheimer's disease (Q50692044)

From Wikidata

Jump to navigation Jump to search

scientific article published on 31 January 2014

Language	Label	Description	Also known as
English	Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP/PS1 double transgenic model of Alzheimer's disease	scientific article published on 31 January 2014

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

Neural stem cell transplants improve cognitive function without altering amyloid pathology in an APP/PS1 double transgenic model of Alzheimer's disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

0 references

neural stem cell

1 reference

based on heuristic

inferred from title

author name string

Wei Zhang

1

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

Pei-Jun Wang

2

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

Hong-ying Sha

3

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

Jiong Ni

4

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

Ming-hua Li

5

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

Guo-jun Gu

6

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

publication date

31 January 2014

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

Molecular Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

50

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

2

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

423-437

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

The Alzheimer's A beta peptide induces neurodegeneration and apoptotic cell death in transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Alzheimer's disease is a synaptic failure

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Pathways towards and away from Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Set back to Alzheimer vaccine studies.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Prevalence of asymptomatic vasogenic edema in pretreatment Alzheimer's disease study cohorts from phase 3 trials of semagacestat and solanezumab

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

γ-secretase inhibitors and modulators for the treatment of Alzheimer's disease: disappointments and hopes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

A phase 1 clinical trial of nerve growth factor gene therapy for Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Effect of immunotherapy with bapineuzumab on cerebrospinal fluid biomarker levels in patients with mild to moderate Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Recent developments in cholinesterases inhibitors for Alzheimer's disease treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Impaired neurogenesis is an early event in the etiology of familial Alzheimer's disease in transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Neurogenic abnormalities in Alzheimer's disease differ between stages of neurogenesis and are partly related to cholinergic pathology

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Human neural progenitor cells over-expressing IGF-1 protect dopamine neurons and restore function in a rat model of Parkinson's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Neural stem cells improve cognition via BDNF in a transgenic model of Alzheimer disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Human neural stem cells over-expressing choline acetyltransferase restore cognition in rat model of cognitive dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Monitoring disease progression in transgenic mouse models of Alzheimer's disease with proton magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Dynamic changes in Ezh2 gene occupancy underlie its involvement in neural stem cell self-renewal and differentiation towards oligodendrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Efficient in vitro labeling of human neural precursor cells with superparamagnetic iron oxide particles: relevance for in vivo cell tracking

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

AAV1/2-mediated CNS gene delivery of dominant-negative CCL2 mutant suppresses gliosis, beta-amyloidosis, and learning impairment of APP/PS1 mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

FGF2 gene transfer restores hippocampal functions in mouse models of Alzheimer's disease and has therapeutic implications for neurocognitive disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Developments of a water-maze procedure for studying spatial learning in the rat

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Intraneuronal Abeta causes the onset of early Alzheimer's disease-related cognitive deficits in transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Progressive age-related impairment of cognitive behavior in APP23 transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

A disintegrin-metalloproteinase prevents amyloid plaque formation and hippocampal defects in an Alzheimer disease mouse model

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Modeling Alzheimer's disease in transgenic mice: effect of age and of presenilin1 on amyloid biochemistry and pathology in APP/London mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Extracellular deposition of beta-amyloid upon p53-dependent neuronal cell death in transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Overexpression of monocyte chemotactic protein-1/CCL2 in beta-amyloid precursor protein transgenic mice show accelerated diffuse beta-amyloid deposition

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Exercise induces mitochondrial biogenesis after brain ischemia in rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Persistent activation of the zeta isoform of protein kinase C in the maintenance of long-term potentiation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Memantine protects hippocampal neuronal function in murine human immunodeficiency virus type 1 encephalitis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Amyloid β-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Impaired performance of female APP/PS1 mice in the Morris water maze is coupled with increased Aβ accumulation and microglial activation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

An improved thioflavine S method for staining neurofibrillary tangles and senile plaques in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Oligomeric amyloid decreases basal levels of brain-derived neurotrophic factor (BDNF) mRNA via specific downregulation of BDNF transcripts IV and V in differentiated human neuroblastoma cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Alzheimer's disease: Abeta, tau and synaptic dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

The expanding role of BDNF: a therapeutic target for Alzheimer's disease?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Down regulation of trk but not p75NTR gene expression in single cholinergic basal forebrain neurons mark the progression of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

NMDA receptor subunit composition determines beta-amyloid-induced neurodegeneration and synaptic loss.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

A Oligomer-Induced Aberrations in Synapse Composition, Shape, and Density Provide a Molecular Basis for Loss of Connectivity in Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Comparative evaluation of synaptophysin-based methods for quantification of synapses

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Protein synthesis required for long-term memory is induced by PKC activation on days before associative learning

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Normal induction but accelerated decay of LTP in APP + PS1 transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Trk receptors: mediators of neurotrophin action

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Neurotrophins as synaptic modulators

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Brain-Derived Neurotrophic Factor/TrkB Signaling in Memory Processes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

BDNF is essential to promote persistence of long-term memory storage

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

BDNF and full-length and truncated TrkB expression in Alzheimer disease. Implications in therapeutic strategies

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

1H-MRS assessment of the therapeutic effect of bilateral intraventricular BDNF infusion into APP/PS1 double transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

The neurotrophic compound J147 reverses cognitive impairment in aged Alzheimer's disease mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

RETRACTED: Elevation of brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer's disease mouse model.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

BDNF, NT-3, and NGF released from transplanted neural progenitor cells promote corticospinal axon growth in organotypic cocultures

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Long-term reversal of cholinergic neuronal decline in aged non-human primates by lentiviral NGF gene delivery

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Detection of behavioral alterations and learning deficits in mice lacking synaptophysin.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Essential roles in synaptic plasticity for synaptogyrin I and synaptophysin I

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Synaptic loss in Alzheimer's disease and other dementias

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Physical basis of cognitive alterations in alzheimer's disease: Synapse loss is the major correlate of cognitive impairment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Effects of engrafted neural stem cells in Alzheimer's disease rats

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

A synaptic model of memory: long-term potentiation in the hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Synaptic plasticity in animal models of early Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Enhanced synaptic plasticity in newly generated granule cells of the adult hippocampus.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Biphasic modulation of protein kinase C and enhanced cell toxicity by amyloid beta peptide and anoxia in neuronal cultures

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Inhibition of postsynaptic PKC or CaMKII blocks induction but not expression of LTP

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

PKC ε activation prevents synaptic loss, Aβ elevation, and cognitive deficits in Alzheimer's disease transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Protein kinase Mzeta is necessary and sufficient for LTP maintenance

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Systemic vaccination with anti-oligomeric monoclonal antibodies improves cognitive function by reducing Aβ deposition and tau pathology in 3xTg-AD mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Directed migration of neural stem cells to sites of CNS injury by the stromal cell-derived factor 1alpha/CXC chemokine receptor 4 pathway

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

The incretin analogue D-Ala2GIP reduces plaque load, astrogliosis and oxidative stress in an APP/PS1 mouse model of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8640-X

21 January 2018

Protein synthesis is required for the enhancement of long-term potentiation and long-term memory by spaced training.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neurotrophins enhance CaMKII activity and rescue amyloid-β-induced deficits in hippocampal synaptic plasticity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bidirectional regulation of protein kinase M zeta in the maintenance of long-term potentiation and long-term depression

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Differential involvement of protein kinase C isozymes in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A hippocampal NR2B deficit can mimic age-related changes in long-term potentiation and spatial learning in the Fischer 344 rat.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of brain-derived neurotrophic factor receptors in the mature hippocampus: modulation of long-term potentiation through a presynaptic mechanism involving TrkB.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein kinase C and lipid signaling for sustained cellular responses

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Selectively reduced expression of synaptic plasticity-related genes in amyloid precursor protein + presenilin-1 transgenic mice.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Protein synthesis-dependent formation of protein kinase Mzeta in long-term potentiation

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term potentiation in the presence of NMDA receptor antagonist arylalkylamine spider toxins

1 reference

https://pubmed.ncbi.nlm.nih.gov/24481678

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12035-014-8640-X

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 March 2018

http://europepmc.org/abstract/MED/24481678

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50692044&oldid=2259575050"